Publikationen in Zusammenarbeit mit Forschern von Hospital Vall d'Hebron (6)

2011

  1. Risk, Predictors, and Clinical Characteristics of Lymphoma Development in Primary Sjögren's Syndrome

    Seminars in Arthritis and Rheumatism, Vol. 41, Núm. 3, pp. 415-423

2009

  1. Successful use of entecavir for a severe case of reactivation of hepatitis B virus following polychemotherapy containing rituximab

    Journal of Hepatology, Vol. 51, Núm. 6, pp. 1091-1096

2008

  1. A prospective observational study of the effectiveness, safety, and effect on fatigue of darbepoetin alfa for the treatment of chemotherapy-induced anaemia

    Current Medical Research and Opinion, Vol. 24, Núm. 10, pp. 2931-2942

  2. GEMOX-R regimen is a highly effective salvage regimen in patients with refractory/relapsing diffuse large-cell lymphoma: A phase II study

    European Journal of Haematology, Vol. 80, Núm. 2, pp. 127-132

2007

  1. Rituximab, gemcitabine and oxaliplatin: An effective regimen in patients with refractory and relapsing mantle cell lymphoma

    Leukemia and Lymphoma, Vol. 48, Núm. 11, pp. 2172-2178

2005

  1. Assessment of the markers of platelet and coagulation activation following transcatheter closure of atrial septal defects

    International Journal of Cardiology, Vol. 98, Núm. 1, pp. 107-112